Nephrogenic Systemic Fibrosis

Nephrology
0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Lantheus Medical Imaging
1 program
AblavarN/A1 trial
Active Trials
NCT01135316CompletedEst. Sep 2013
Guerbet
GuerbetFrance - Villepinte
1 program
Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following N/A1 trial
Active Trials
NCT00811863Withdrawn0Est. May 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Lantheus Medical ImagingAblavar
GuerbetEvaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following

Clinical Trials (2)

NCT01135316Lantheus Medical ImagingAblavar

Prospective Evaluation of the Incidence of NSF in Patients With Kidney Disease Undergoing MR

Start: Oct 2009Est. completion: Sep 2013
N/ACompleted
NCT00811863GuerbetEvaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following

Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection

Start: Feb 2009Est. completion: May 20120
N/AWithdrawn

Related Jobs in Nephrology

Thesis work, 60 credits – Establishing In Vitro Models of Mitochondrial Dysfunction in Acute Kidney Injury for Preclinical Drug Discovery

AstraZeneca
Sweden - Gothenburg
1w ago

Associate Director – Nephrology Market Access Strategy

Biogen
Cambridge, MA
1w ago
$164K - $226K/yr

Director, Strategy & Operations-Nephrology Franchise

Biogen
Cambridge, MA
1w ago
$195K - $269K/yr

Medical Science Liaison, CardioRenal - Portland, OR

AstraZeneca
Portland - OR, US
1w ago

Vice President, Head of Renal Sales

Novartis
Field Non-Sales (USA)
1w ago
$274K - $510K/yr

Specialty Account Manager, Nephrology- South Houston, Texas

Amgen
Texas - Houston, US
1w ago
$155K - $184K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

Related Indications

Chronic Kidney Disease(86)Renal Impairment(67)End Stage Renal Disease(56)Kidney Transplantation(49)Renal Insufficiency(27)Chronic Kidney Diseases(25)Kidney Transplant(19)Diabetic Nephropathies(18)Kidney Diseases(17)Kidney Transplant Rejection(16)